PRMT5 and mantle cell lymphoma: To interrogate the role of PRMT5 upregulation on p53 expression in MCL, we treated MCL cell lines expressing wild-type p53 (Z-138, Granta-519, and JVM-2) with GSK3326595 and LLY-283.